The microorganisms in chronically infected end-stage and non-end-stage cystic fibrosis patients.

Patients suffering from cystic fibrosis (CF) develop chronic lung infections because of highly viscous mucus, where bacteria can form biofilms. In this study, we investigated the microorganisms present in the lungs of end-stage and non-end-stage patients using standard culturing techniques and molecular methods. Tissue and sputum samples (n = 34) from explanted lungs of five end-stage patients were examined along with routine expectorates (n = 15) from 13 patients with non-end-stage CF, representing earlier stages of chronic lung infections. Previously, using peptide nucleic acid (PNA) fluorescence in situ hybridization (FISH), we have shown that Pseudomonas aeruginosa was the sole pathogen in end-stage CF lungs (Pediatr Pulmonol 2009, 44: 547). In this study, this tendency was supported by the results of real-time PCR, confirming previous results obtained by standard culturing and 16S rRNA gene analysis (J Clin Microbiol 2011, 49: 4352). Conversely, the non-end-stage patients were found to harbor several species by culturing. PNA FISH confirmed heterogeneous microbiota and showed that the bacteria were located in monospecies aggregates with no apparent physical interaction between the different microcolonies. In conclusion, standard culturing identifies the dominating pathogens, which seem to reside in monospecies microcolonies. The possibility of signaling between the distinct microcolonies still has to be verified and elucidated.

[1]  P. Nielsen,et al.  True Microbiota Involved in Chronic Lung Infection of Cystic Fibrosis Patients Found by Culturing and 16S rRNA Gene Analysis , 2011, Journal of Clinical Microbiology.

[2]  C. Merlo,et al.  Cystic fibrosis lung transplantation , 2011, Current opinion in pulmonary medicine.

[3]  Forest Rohwer,et al.  Spatial distribution of microbial communities in the cystic fibrosis lung , 2011, The ISME Journal.

[4]  M. Wolfgang,et al.  Analysis of the Bacterial Communities Present in Lungs of Patients with Cystic Fibrosis from American and British Centers , 2010, Journal of Clinical Microbiology.

[5]  Thomas Bjarnsholt,et al.  Biofilms in chronic infections - a matter of opportunity - monospecies biofilms in multispecies infections. , 2010, FEMS immunology and medical microbiology.

[6]  A. Walker,et al.  Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity , 2010, Expert review of molecular diagnostics.

[7]  M. Vaneechoutte,et al.  Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients , 2009, BMC Microbiology.

[8]  T. Tolker-Nielsen,et al.  Nonrandom Distribution of Pseudomonas aeruginosa and Staphylococcus aureus in Chronic Wounds , 2009, Journal of Clinical Microbiology.

[9]  N. Høiby,et al.  Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients , 2009, Pediatric pulmonology.

[10]  G. Döring,et al.  Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[11]  S. Molin,et al.  Novel experimental Pseudomonas aeruginosa lung infection model mimicking long-term host–pathogen interactions in cystic fibrosis , 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[12]  S. Bell,et al.  Identification of Pseudomonas aeruginosa by a duplex real-time polymerase chain reaction assay targeting the ecfX and the gyrB genes. , 2009, Diagnostic microbiology and infectious disease.

[13]  T. Tolker-Nielsen,et al.  Distribution, Organization, and Ecology of Bacteria in Chronic Wounds , 2008, Journal of Clinical Microbiology.

[14]  S. Dowd,et al.  Survey of bacterial diversity in chronic wounds using Pyrosequencing, DGGE, and full ribosome shotgun sequencing , 2008, BMC Microbiology.

[15]  Freya Harrison,et al.  Microbial ecology of the cystic fibrosis lung. , 2007, Microbiology.

[16]  N. Høiby,et al.  Chronic infection with Achromobacter xylosoxidans in cystic fibrosis patients; a retrospective case control study. , 2006, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[17]  G. Rogers,et al.  Use of 16S rRNA Gene Profiling by Terminal Restriction Fragment Length Polymorphism Analysis To Compare Bacterial Communities in Sputum and Mouthwash Samples from Patients with Cystic Fibrosis , 2006, Journal of Clinical Microbiology.

[18]  N. Høiby,et al.  Eradication of early Pseudomonas aeruginosa infection. , 2005, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[19]  M. Denton,et al.  Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by patients with cystic fibrosis. , 2005, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[20]  J. Dinman,et al.  Systematic analysis of bicistronic reporter assay data , 2004, Nucleic acids research.

[21]  S. Kjelleberg,et al.  Real-Time Quantitative PCR for Assessment of Abundance of Pseudoalteromonas Species in Marine Samples , 2004, Applied and Environmental Microbiology.

[22]  R. Boucher,et al.  New concepts of the pathogenesis of cystic fibrosis lung disease , 2004, European Respiratory Journal.

[23]  P. Vandamme,et al.  Epidemic spread of Pandoraea apista, a new pathogen causing severe lung disease in cystic fibrosis patients , 2003, Pediatric pulmonology.

[24]  H. Stender PNA FISH: an intelligent stain for rapid diagnosis of infectious diseases , 2003, Expert review of molecular diagnostics.

[25]  M. Conese,et al.  Neutrophil recruitment and airway epithelial cell involvement in chronic cystic fibrosis lung disease. , 2003, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[26]  M. Wagner,et al.  Comparison of Different Approaches To QuantifyStaphylococcus aureus Cells by Real-Time Quantitative PCR and Application of This Technique for Examination of Cheese , 2001, Applied and Environmental Microbiology.

[27]  Richard I. Jaffe,et al.  Real‐time identification of Pseudomonas aeruginosa direct from clinical samples using a rapid extraction method and polymerase chain reaction (PCR) , 2001, Journal of clinical laboratory analysis.

[28]  J. Costerton,et al.  Bacterial biofilms: a common cause of persistent infections. , 1999, Science.

[29]  P. Gilligan,et al.  Microbiology of airway disease in patients with cystic fibrosis , 1991, Clinical Microbiology Reviews.

[30]  R. Koch,et al.  Die Aetiologie der Tuberkulose , 1932, Klinische Wochenschrift.

[31]  N. Høiby,et al.  Methods to classify bacterial pathogens in cystic fibrosis. , 2011, Methods in molecular biology.

[32]  S. Lory,et al.  Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis , 2011, The ISME Journal.

[33]  N. Høiby,et al.  Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. , 2010, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[34]  K. Krogfelt,et al.  Why chronic wounds will not heal: a novel hypothesis , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[35]  G. Rogers,et al.  Use of 16 S rRNA Gene Profiling by Terminal Restriction Fragment Length Polymorphism Analysis To Compare Bacterial Communities in Sputum and Mouthwash Samples from Patients with Cystic Fibrosis † , 2006 .

[36]  L. Saiman Microbiology of early CF lung disease. , 2004, Paediatric respiratory reviews.